Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PYPL vs GSK✓SelectedUSD · GSKPYPL vs GSK performance historyLatest closeAs of-0.38%11/18
Stock and ETF performance explorer

PYPL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-70.8%
GSK return
+42.7%
Excess return
-113.5%
Maximum drawdown
-80.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.4%-1.3%+1.0%-0.2%
7D-2.7%-3.1%+0.5%-2.2%
30D+2.4%-0.9%+3.3%+2.5%
3M-4.0%-4.2%+0.2%-3.5%
6M+31.2%-1.6%+32.8%+31.2%
YTD0.0%+2.6%-2.6%-1.1%
1Y-3.6%+6.2%-9.8%-5.3%
3Y+3.5%+55.0%-51.4%-8.2%
5Y-70.8%+42.8%-113.6%-75.4%
All-70.8%+42.7%-113.5%-75.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling